Loading: 100%
Evolent Health, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 2,400 (as per Q2 2017)no data available
Sector Application Software, TechnologyApplication Software, Technologyno data available
Ticker EVHno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common Shares, Class ANov. 16Jan. 17März 17Mai 17Juli 17Sep. 171015202530
datesClosing price (adj.)
13.10.201716.50
11.10.201716.65
04.10.201718.60
27.09.201716.65
20.09.201715.65
13.09.201717.95
06.09.201717.70
30.08.201716.55
23.08.201717.65
16.08.201717.25
09.08.201718.15
02.08.201724.15
26.07.201726.10
19.07.201726.35
12.07.201726.05
05.07.201725.50
27.06.201725.20
20.06.201726.50
13.06.201725.45
06.06.201726.00
30.05.201722.70
23.05.201723.35
16.05.201724.05
09.05.201724.05
02.05.201723.60
25.04.201722.90
18.04.201721.75
11.04.201722.25
04.04.201722.70
28.03.201720.55
21.03.201720.65
14.03.201720.20
07.03.201719.05
28.02.201719.70
21.02.201719.95
14.02.201718.65
07.02.201718.15
31.01.201718.20
24.01.201718.20
17.01.201719.00
10.01.201716.75
03.01.201714.90
27.12.201615.55
19.12.201616.40
12.12.201616.60
05.12.201617.70
28.11.201620.30
21.11.201620.70
14.11.201617.20
07.11.201618.90
31.10.201621.05
24.10.201623.50
17.10.201622.75
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
16.50n/a
Market Capitalisation
in million USD
1,122n/a
Enterprise Value
in million USD
1,244n/a
Common Shares Outstanding
as per Mar 31, 2017
67,975,078n/a
Preferred Shares Outstanding
as per Mar 31, 2017
7,400,000n/a
Average Basic Shares Outstanding
TTM
51,864,750n/a
Average Diluted Shares Outstanding
TTM
51,864,750n/a
Index Membership
n/a
Business Summary
Evolent Health Inc is engaged in healthcare delivery and payment. It markets and sells its services to providers throughout the United States.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 0n/a
Receivables 0n/a
Total Current Assets 0n/a
PP&E 0n/a
Total Assets 37n/a
Accounts Payable 0n/a
Current Debt 0n/a
Total Current Liabilities 0n/a
Long-Term Debt 0n/a
Total Liabilities 0n/a
Total Equity 37n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.03n/a
Other Ratios
Current Ratio 0.0%n/a
Liabilities to Equity Ratio 0.0%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 71% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Revenue
26
0
97
254
Sales & Services Revenue
0
0
0
0
Financing Revenue
0
0
0
0
Other Revenue
0
0
0
0
Cost of revenue
-30
0
-57
-155
Cost of Goods & Services
0
0
0
0
Cost of Financing Revenue
0
0
0
0
Cost of Other Revenue
0
0
0
0
Gross Profit
-4
0
39
99
Other Operating Income
0
0
0
0
Operating Expenses
-17
0
-82
-178
Selling, General & Administrative
-16
0
-75
-161
Selling & Marketing
0
0
0
0
General & Administrative
0
0
0
0
Research & Development
0
0
0
0
Depreciation & Amortization
-1
0
-7
-17
Provision For Doubtful Accounts
0
0
0
0
Other Operating Expense
0
0
0
0
Operating Income (Loss)
-21
0
-43
-79
Non-Operating Income (Loss)
-5
-25
-28
0
Interest Expense, net
-1
0
0
1
Interest Expense
0
0
0
0
Interest Income
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
Income (Loss) from Affiliates
-4
-25
-28
-1
Other Non-Operating Income (Loss)
0
0
0
0
Pretax Income (Loss), Adjusted
-26
-25
-71
-79
Abnormal Gains (Losses)
46
0
414
-159
Acquired In-Process R&D
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
Abnormal Derivatives
0
0
0
0
Disposal of Assets
0
0
0
0
Early extinguishment of Debt
0
0
0
0
Asset Write-Down
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
Sale of Business
0
0
0
0
Legal Settlement
0
0
0
0
Restructuring Charges
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
Insurance Settlement
0
0
0
0
Other Abnormal Items
0
0
0
0
Pretax Income (Loss)
20
-25
343
-238
Income Tax (Expense) Benefit, net
0
0
-23
11
Current Income Tax
0
0
0
0
Deferred Income Tax
0
0
0
0
Tax Allowance/Credit
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
Income (Loss) from Continuing Operations
20
-25
320
-227
Net Extraordinary Gains (Losses)
0
0
0
0
Discontinued Operations
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
Income (Loss) Including Minority Interest
20
-25
320
-227
Minority Interest
0
0
13
67
Net Income
20
-25
332
-160
Preferred Dividends
0
0
0
0
Other Adjustments
0
0
0
0
Net Income Available to Common Shareholders
20
-25
332
-160
Remarks
restated on Feb 29, 2016 n/a
calculated values,
restated on Mar 3, 2017 n/a
calculated values,
restated on Mar 3, 2017 n/a
calculated values,
restated on Mar 3, 2017 n/a
calculated values,
Balance SheetBS data quality: 55% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
0
155
179
Cash & Cash Equivalents
n/a
0
146
135
Short Term Investments
n/a
0
9
44
Accounts & Notes Receivable
n/a
0
20
41
Accounts Receivable, Net
n/a
0
20
41
Notes Receivable, Net
n/a
0
0
0
Unbilled Revenues
n/a
0
0
0
Inventories
n/a
0
0
0
Raw Materials
n/a
0
0
0
Work In Process
n/a
0
0
0
Finished Goods
n/a
0
0
0
Other Inventory
n/a
0
0
0
Other Short Term Assets
n/a
0
9
45
Prepaid Expenses
n/a
0
4
11
Derivative & Hedging Assets
n/a
0
0
0
Assets Held-for-Sale
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Income Taxes Receivable
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Miscellaneous Short Term Assets
n/a
0
5
34
Total Current Assets
n/a
0
184
265
Property, Plant & Equipment, Net
n/a
0
13
31
Property, Plant & Equipment
n/a
0
0
0
Accumulated Depreciation
n/a
0
0
0
Long Term Investments & Receivables
n/a
0
45
0
Long Term Investments
n/a
0
0
0
Long Term Marketable Securities
n/a
0
0
0
Long Term Receivables
n/a
0
0
0
Other Long Term Assets
n/a
37
774
904
Intangible Assets
n/a
0
163
259
Goodwill
n/a
0
609
627
Other Intangible Assets
n/a
0
0
0
Prepaid Expense
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
Prepaid Pension Costs
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Investments in Affiliates
n/a
37
0
2
Miscellaneous Long Term Assets
n/a
0
2
16
Total Noncurrent Assets
n/a
37
831
935
Total Assets
n/a
37
1,016
1,200
Liabilities and owners' equity
Payables & Accruals
n/a
0 0
45 44671000
111 111460000
Accounts Payable
n/a
0 0
17 16699000
44 43892000
Accrued Taxes
n/a
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
28 27972000
68 67568000
Short Term Debt
n/a
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
15 14835000
20 20481000
Deferred Revenue
n/a
0 0
15 14835000
20 20481000
Derivatives & Hedging
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
Total Current Liabilities
n/a
0 0
60 59506000
132 131941000
Long Term Debt
n/a
0 0
0 0
120 120283000
Long Term Borrowings
n/a
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
Other Long Term Liabilities
n/a
0 0
21 21429000
36 35501000
Accrued Liabilities
n/a
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
21 21318000
21 20846000
Derivatives & Hedging
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 0
0 111000
15 14655000
Total Noncurrent Liabilities
n/a
0 0
21 21429000
156 155784000
Total Liabilities
n/a
0 0
81 80935000
288 287725000
Preferred Equity
n/a
39 39273000
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
24 23733000
342 342063000
555 555250000
Common Stock
n/a
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
Retained Earnings
n/a
-26 -25806000
307 306688000
147 146617000
Other Equity
n/a
0 0
0 0
0 0
Equity Before Minority Interest
n/a
37 37200000
649 648751000
702 701867000
Minority Interest
n/a
0 0
285 285238000
210 209588000
Total Equity
n/a
37 37200000
934 933989000
911 911455000
Total Liabilities & Equity
n/a
37 37200000
1,015 1014924000
1,199 1199180000
Remarks restated on n/a restated on Feb 29, 2016 n/a restated on Mar 3, 2017 n/a restated on Aug 7, 2017 n/a
Cash Flow StatementCF data quality: 88% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '13FY '14FY '15FY '16
Net Income/Starting Line
20
-25
320
-227
Net Income
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
Other Adjustments
0
0
0
0
Depreciation & Amortization
1
0
7
17
Non-Cash Items
-41
25
-348
175
Stock-Based Compensation
0
0
0
0
Deferred Income Taxes
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
Change in Working Capital
6
0
2
0
(Increase) Decrease in Accounts Receivable
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
Cash from Operating Activities
-14
0
-18
-35
Change in Fixed Assets & Intangibles
-10
0
-7
-16
Disposition of Fixed Assets & Intangibles
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
Net Change in Long Term Investment
0
0
-50
9
Decrease in Long Term Investment
0
0
0
0
Increase in Long Term Investment
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
-86
Net Cash from Divestitures
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
Cash for Joint Ventures
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
Other Investing Activities
-15
0
13
-6
Net Cash From Discontinued Operations (investing)
0
0
0
0
Cash from Investing Activities
-26
0
-44
-98
Dividends Paid
0
0
0
0
Cash From (Repayment of) Debt
23
0
209
121
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
Cash From Long Term Debt
0
0
0
0
Cash From (Repurchase of) Equity
0
0
0
1
Increase in Capital Stock
0
0
0
1
Decrease in Capital Stock
0
0
0
0
Other Financing Activities
0
0
-1
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
Cash from Financing Activities
23
0
208
122
Net Cash Before Disc. Operations and FX
-17
0
146
-11
Change in Cash from Disc. Operations and Other
0
0
0
0
Net Cash Before FX
-17
0
146
-11
Effect of Foreign Exchange Rates
0
0
0
0
Net Changes in Cash
-17
0
146
-11
Remarks
restated on Feb 29, 2016 n/a
calculated values,
restated on Mar 3, 2017 n/a
calculated values,
restated on Mar 3, 2017 n/a
calculated values,
restated on Mar 3, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo